Fierce Pharma Biopharma News & Insights
Nov 4, 2024 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
Sep 28, 2018 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...
Top 20 pharma companies by 2023 revenue - Fierce Pharma
Apr 15, 2024 · J&J was No. 1 in 2023 by a comfortable margin over No. 2 Roche, which raked in sales of $58.7 billion Swiss francs ($67 billion) last year. J&J’s big lead is especially noteworthy considering ...
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
Mar 29, 2021 · The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
Pharma | Fierce Pharma
Oct 14, 2024 · Lilly touts winning tirzepatide data in prediabetes patients. Lilly on Wednesday laid out full results from its longest completed study of the dual GIP/GLP-1 receptor agonist tirzepatide to date ...
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
Many producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were ...
First generics to Bristol-Myers and Pfizer's Eliquis are here. But can ...
Dec 26, 2019 · As Bristol's best-selling drug before the Celgene merger—even ahead of PD-1 inhibitor Opdivo—the drug delivered $5.9 billion to the company’s top line in the first nine months of 2019.
FDA approves first T-cell therapy for a solid tumor - Fierce Pharma
Feb 17, 2024 · FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor. The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the ...
The top 15 blockbuster patent expirations coming this decade
Jul 12, 2021 · The biggest names set to face generic pressure in the coming years include the top four of the industry’s best-selling drugs in 2020: Humira, Keytruda, Revlimid and Eliquis. In all, nine of the ...